EVA1A and neoplasm: Taken together, these results indicated that EVA1A reversed the tumor-inhibiting effect of miR-125b in xenograft tumors from oxaliplatin-resistant cells and promoted metastasis, confirming that miR-125b plays a role in preventing oxaliplatin resistance by downregulating its target EVA1A.